Keisuke Miki

865 total citations
57 papers, 554 citations indexed

About

Keisuke Miki is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Keisuke Miki has authored 57 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 29 papers in Epidemiology and 16 papers in Infectious Diseases. Recurrent topics in Keisuke Miki's work include Mycobacterium research and diagnosis (24 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers) and Tuberculosis Research and Epidemiology (14 papers). Keisuke Miki is often cited by papers focused on Mycobacterium research and diagnosis (24 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers) and Tuberculosis Research and Epidemiology (14 papers). Keisuke Miki collaborates with scholars based in Japan and China. Keisuke Miki's co-authors include Mari Miki, Ryoji Maekura, Seigo Kitada, Kenji Yoshimura, Toru Hiraga, Hiroyuki Kagawa, Kazuyuki Tsujino, Hiroshi Kida, Hisako Hashimoto and Takanori Matsuki and has published in prestigious journals such as Scientific Reports, Journal of Bacteriology and Journal of Clinical Microbiology.

In The Last Decade

Keisuke Miki

50 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keisuke Miki Japan 13 264 261 170 91 76 57 554
Yohei Funatsu Japan 14 173 0.7× 232 0.9× 128 0.8× 65 0.7× 55 0.7× 27 436
Gyl Eanes Barros Silva Brazil 14 89 0.3× 119 0.5× 35 0.2× 29 0.3× 194 2.6× 72 550
Michael Boyars United States 11 129 0.5× 167 0.6× 119 0.7× 44 0.5× 87 1.1× 32 570
Hirofumi Kamata Japan 17 223 0.8× 284 1.1× 174 1.0× 55 0.6× 69 0.9× 52 628
Saori Takata Japan 11 113 0.4× 89 0.3× 60 0.4× 22 0.2× 49 0.6× 37 347
George Papadopoulos Greece 13 133 0.5× 276 1.1× 290 1.7× 22 0.2× 59 0.8× 36 562
Gado Napo‐Koura Togo 11 62 0.2× 127 0.5× 54 0.3× 20 0.2× 89 1.2× 69 349
Xinliang Lu China 11 142 0.5× 119 0.5× 79 0.5× 21 0.2× 155 2.0× 33 448
Carlos Capela Portugal 7 58 0.2× 81 0.3× 196 1.2× 20 0.2× 40 0.5× 18 393
Hélio Pinczowski Brazil 10 71 0.3× 113 0.4× 132 0.8× 15 0.2× 59 0.8× 18 385

Countries citing papers authored by Keisuke Miki

Since Specialization
Citations

This map shows the geographic impact of Keisuke Miki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Miki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Miki more than expected).

Fields of papers citing papers by Keisuke Miki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Miki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Miki. The network helps show where Keisuke Miki may publish in the future.

Co-authorship network of co-authors of Keisuke Miki

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Miki. A scholar is included among the top collaborators of Keisuke Miki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Miki. Keisuke Miki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yatera, Kazuhiro, Zhang Wang, Yoko Shibata, et al.. (2025). Sputum Microbiome, Potentially Pathogenic Organisms, and Clinical Outcomes in Japanese Patients with COPD and Moderate Airflow Limitation: The Prospective AERIS-J Study. International Journal of COPD. Volume 20. 1477–1492.
2.
Matsumoto, Yuki, Kiyoharu Fukushima, Shu Zhang, et al.. (2025). mlstverse-web: advancing real-time identification of mycobacteria from sputum using targeted sequencing NALC-Seq. Functional & Integrative Genomics. 25(1). 105–105.
3.
Miki, Mari, Keisuke Miki, Hiroyuki Kagawa, et al.. (2024). The diagnostic impact of fractional exhaled nitric oxide for asthmatic cough in nontuberculous mycobacterial pulmonary disease. BMC Pulmonary Medicine. 24(1). 210–210. 1 indexed citations
4.
Miyamoto, Satoshi, Keisuke Miki, Seigo Kitada, et al.. (2024). Exercise intolerance and oxygen dynamics in nontuberculous mycobacteria with bronchiectasis. Respiratory Investigation. 62(6). 1058–1063.
5.
Iwahori, Kota, Takuro Nii, Takahiro Kawasaki, et al.. (2023). A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19. Scientific Reports. 13(1). 13809–13809. 1 indexed citations
6.
Hashimoto, Kazuki, Takuro Nii, M. Yokoyama, et al.. (2023). Diagnosis and Management of Drug-Induced Interstitial Lung Disease Associated with Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium Avium Complex Pulmonary Disease: A Case Report. Infection and Drug Resistance. Volume 16. 6629–6634. 2 indexed citations
7.
Miki, Keisuke, Kazuyuki Tsujino, Motonari Fukui, et al.. (2023). Laryngeal widening and adequate ventilation by expiratory pressure load training improve aerobic capacity in COPD: a randomised controlled trial. Thorax. 79(1). 23–34. 3 indexed citations
8.
Fukushima, Kiyoharu, Seigo Kitada, Sho Komukai, et al.. (2021). First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease. Scientific Reports. 11(1). 1178–1178. 18 indexed citations
9.
Kagawa, Hiroyuki, Kazuyuki Tsujino, Yuji Yamamoto, et al.. (2020). Acute lung injury after plasma exchange in a patient with anti-MDA5 antibody-positive, rapidly progressive, interstitial lung disease：A case report. Respiratory Medicine Case Reports. 29. 101016–101016. 12 indexed citations
10.
Hara, Reina, Seigo Kitada, Tomoki Kuge, et al.. (2020). Diagnostic Validity of Gastric Aspirate Culture in Nontuberculous Mycobacterial Pulmonary Disease. Annals of the American Thoracic Society. 17(12). 1536–1541. 2 indexed citations
11.
Yamamoto, Yuji, Kazuyuki Tsujino, Tomoki Kuge, et al.. (2020). Pleuroparenchymal fibroelastosis inMycobacterium aviumcomplex pulmonary disease: clinical characteristics and prognostic impact. ERJ Open Research. 7(1). 765–2020. 10 indexed citations
12.
Yamamoto, Yuji, Keisuke Miki, Takanori Matsuki, et al.. (2020). <p>Evaluation of Exertional Ventilatory Parameters Using Oscillometry in COPD</p>. International Journal of COPD. Volume 15. 1697–1711. 3 indexed citations
13.
Yamamoto, Yuji, Keisuke Miki, Kazuyuki Tsujino, et al.. (2020). Evaluation of disease severity in bronchiectasis using impulse oscillometry. ERJ Open Research. 6(4). 53–2020. 8 indexed citations
14.
Kuge, Tomoki, Kiyoharu Fukushima, Yuki Matsumoto, et al.. (2020). Pulmonary disease caused by a newly identified mycobacterium: Mycolicibacterium toneyamachuris: a case report. BMC Infectious Diseases. 20(1). 888–888. 3 indexed citations
15.
Miki, Keisuke, et al.. (2019). <p>Clinical Effects Of Acupuncture On The Pathophysiological Mechanism Of Chronic Obstructive Pulmonary Disease During Exercise</p>. International Journal of COPD. Volume 14. 2787–2798. 12 indexed citations
16.
Hosono, Yuki, Seigo Kitada, Yukihiro Yano, et al.. (2018). The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study. Journal of Infection and Chemotherapy. 24(5). 353–357. 7 indexed citations
17.
Miki, Keisuke, Ryoji Maekura, Seigo Kitada, et al.. (2017). Pulmonary rehabilitation for COPD improves exercise time rather than exercise tolerance: effects and mechanisms. International Journal of COPD. Volume 12. 1061–1070. 12 indexed citations
18.
Maekura, Ryoji, Toru Hiraga, Keisuke Miki, et al.. (2015). Personalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary disease. International Journal of COPD. 10. 1787–1787. 24 indexed citations
19.
Kitada, Seigo, Kenji Yoshimura, Keisuke Miki, et al.. (2014). Validation of a commercial serodiagnostic kit for diagnosing pulmonary <I>Mycobacterium avium</I> complex disease. The International Journal of Tuberculosis and Lung Disease. 19(1). 97–103. 19 indexed citations
20.
Miki, Keisuke, Ryoji Maekura, Toru Hiraga, et al.. (2010). Exertional dyspnea-related acidotic and sympathetic responses in patients with sequelae of pulmonary tuberculosis. The Journal of Physiological Sciences. 60(3). 187–193. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yohei Funatsu Breakdown of academic impact, for papers by Gyl Eanes Barros Silva Breakdown of academic impact, for papers by Michael Boyars Breakdown of academic impact, for papers by Hirofumi Kamata Breakdown of academic impact, for papers by Saori Takata Breakdown of academic impact, for papers by George Papadopoulos Breakdown of academic impact, for papers by Gado Napo‐Koura Breakdown of academic impact, for papers by Xinliang Lu Breakdown of academic impact, for papers by Carlos Capela Breakdown of academic impact, for papers by Hélio Pinczowski
Rankless by CCL
2026